Nykode Therapeutics (formerly known as Vaccibody) is a biopharmaceutical company dedicated to the discovery and development of immunotherapies. It utilizes a proprietary vaccine platform designed to generate antibody and T cell responses. Vaccibody product pipeline includes a therapeutic vaccine against cervical precancerous lesions and therapeutic cancer vaccines against tumor-specific antigens.